| Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells S Paglin, NY Lee, C Nakar, M Fitzgerald, J Plotkin, B Deuel, N Hackett, ... Cancer research 65 (23), 11061-11070, 2005 | 260 | 2005 |
| Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres C Nakar, MJ Manco‐Johnson, A Lail, S Donfield, J Maahs, Y Chong, ... Haemophilia 21 (3), 365-373, 2015 | 57 | 2015 |
| Eukaryotic Initiation Factor 2α-a Downstream Effector of Mammalian Target of Rapamycin-Modulates DNA Repair and Cancer Response to Treatment L Tuval-Kochen, S Paglin, G Keshet, Y Lerenthal, C Nakar, T Golani, ... PloS one 8 (10), e77260, 2013 | 54 | 2013 |
| Adenovirus infection in hospitalized immunocompetent children N Peled, C Nakar, H Huberman, E Scherf, Z Samra, Y Finkelstein, ... Clinical pediatrics 43 (3), 223-229, 2004 | 53 | 2004 |
| Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the … NA Goldenberg, JM Kittelson, TC Abshire, M Bonaca, JF Casella, ... Jama 327 (2), 129-137, 2022 | 48 | 2022 |
| Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency AD Shapiro, C Nakar, JM Parker, GR Albert, JE Moran, K Thibaudeau, ... Blood, The Journal of the American Society of Hematology 131 (12), 1301-1310, 2018 | 41 | 2018 |
| Hemophilia A with inhibitor: immune tolerance induction (ITI) in the mirror of time C Nakar, A Shapiro Transfusion and Apheresis Science 58 (5), 578-589, 2019 | 27 | 2019 |
| An international registry of patients with plasminogen deficiency (HISTORY) AD Shapiro, M Menegatti, R Palla, M Boscarino, C Roberson, P Lanzi, ... haematologica 105 (3), 554, 2020 | 21 | 2020 |
| 3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP.(Summary of 2 Pilot Studies). CT Nakar, JB Bussel Blood 114 (22), 2404, 2009 | 19 | 2009 |
| Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the … C Nakar, DL Cooper, D DiMichele Haemophilia 16 (4), 625-631, 2010 | 16 | 2010 |
| Mycetoma of the renal pelvis caused by Fusarium species C Nakar, G Livny, I Levy, Z Samra, N Linder, S Ashkenazi, P Livne, ... The Pediatric infectious disease journal 20 (12), 1182-1183, 2001 | 12 | 2001 |
| Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label SE Croteau, C Nakar, EJ Neufeld, A Shapiro, DL Cooper Pediatric blood & cancer 63 (10), 1822-1828, 2016 | 8 | 2016 |
| Treatment of ligneous conjunctivitis with plasminogen eyedrops R Caputo, AD Shapiro, MT Sartori, A Leonardi, BH Jeng, C Nakar, ... Ophthalmology 129 (8), 955-957, 2022 | 7 | 2022 |
| Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX: C deficiency vs. controls S Gupta, MC Bravo, M Heiman, C Nakar, K Brummel-Ziedins, CH Miller, ... Thrombosis research 182, 43-50, 2019 | 5 | 2019 |
| Clinical features of children, adolescents, and adults with coexisting hypermobility syndromes and von Willebrand disease SA Hall, ER Meier, S Gupta, C Nakar, A Rampersad, N Bakeer, ... Pediatric Blood & Cancer 65 (12), e27370, 2018 | 5 | 2018 |
| Safety & efficacy of human plasma derived plasminogen ophthalmic drops for treatment of ligneous conjunctivitis: report of phase 2/3 clinical trial CT Nakar, R Caputo, FW Price Jr, MT Sartori, A Leonardi, AL Suffredini, ... Blood 126 (23), 2288, 2015 | 4 | 2015 |
| Functional Fibrinolysis Assays Reveal Different Mechanisms underlying Plasminogen Dysfunction in Ligneous Conjunctivitis MC Bourrienne, S Loyau, D Faille, E de Raucourt, P de Mazancourt, ... Thrombosis and Haemostasis 120 (05), 758-767, 2020 | 3 | 2020 |
| Prompt immune tolerance induction at inhibitor diagnosis regardless of titer may increase overall success in hemophilia A with inhibitors: experience of two US centers CT Nakar, MJ Manco-Johnson, A Lail, SM Donfield, J Maahs, Y Chong, ... Blood 122 (21), 575, 2013 | 3 | 2013 |
| Plasminogen, human‐tvmh for the treatment of children and adults with plasminogen deficiency type 1 AD Shapiro, C Nakar, JM Parker, K Thibaudeau, R Crea, PM Sandset Haemophilia 29 (6), 1556-1564, 2023 | 2 | 2023 |
| Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders OO Olasupo, C Haddix, C Nakar, J Maahs, A Greist, A Ghafoor, ... European Journal of Haematology 108 (3), 232-243, 2022 | 2 | 2022 |
